N P Quinn, A E Lang, C Thompson, S Brincat, C D Marsden, J D Parkes. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useDomperidone/administration & dosageErgolines/adverse effectsErgolines/therapeutic useHumansLevodopa/administration & dosageMental Disorders/chemically inducedParkinson Disease/drug therapyParkinson Disease, Postencephalitic/drug therapyPergolide
Substances： See more » Antiparkinson AgentsErgolinesPergolideLevodopaDomperidone
Year: 1984 PMID： 6695628
Source DB: PubMed Journal: Adv Neurol ISSN： 0091-3952